Abeona Therapeutics Profit Margin

The latest profit margin for ABEO is -246.42% as of June 2026. That compares with 14310.5% in the prior-year period — down 101.7% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Abeona Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, ABEO's profit margin moved from 14310.5% to -246.42% — a 101.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Abeona Therapeutics's valuation or profitability profile.

Against Healthcare companies, ABEO currently prints -246.42% for profit margin, while the sector average sits near 13.89%. That is roughly 1873.7% below the sector mean. Large gaps often invite a closer look at Abeona Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Abeona Therapeutics converts resources into returns. At -246.42%, ABEO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14310.5% in the prior-year period — down 101.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ABEO's profit margin (-246.42%), review year-over-year change from 14310.5%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.